U.S. Preventive Services Task Force issued recommendation on screening for obstructive sleep apnea in adults
On Nov. 15, 2022, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
On Nov. 15, 2022, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
On Nov. 15, 2022, Roche announced that the U.S. Food and Drug Administration had granted Emergency Use Authorization…
On Nov. 15, 2022, the U.S. Food and Drug Administration conditionally approved Panoquell-CA1 (fuzapladib sodium for injection) for…
On Nov. 14, 2022, Moderna announced that both of Moderna’s bivalent Omicron-targeting booster candidates (mRNA-1273.214 and mRNA-1273.222) trigger…
On Nov. 14, 2022, researchers discovered the pathway by which chronic hyperglycaemia reduces β-cell function. Their data also…
On Nov. 10, 2022, Pfizer and BioNTech announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine…
On Nov. 10, 2022, researchers from the Okinawa Institute of Science and Technology (OIST), in collaboration with K….
On Nov. 9, 2022, researchers at the University of Missouri announced they had identified the highly prevalent, specific…
On Nov. 9, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
On Nov. 8, 2022, Novavax announced topline results from its Phase 3 Boosting Trial for the SARS-CoV-2 rS…
On Nov. 7, 2022, the NHS Blood and Transplant (NHSBT) reported that red blood cells grown in a…
On Nov. 5, 2022, the U.S. Department of Agriculture’s (USDA) Animal Plant Health Inspection Service (APHIS) confirmed the…
On Nov. 4, 2022, the Oregon Department of Agriculture (ODA) and the U.S. Department of Agriculture’s (USDA) Animal…
On Nov. 4, 2022, Moderna announced that Health Canada had authorized the use of its BA.4/BA.5 Omicron-targeting bivalent…
On Nov. 4, 2022, the U.S. Department of Agriculture’s (USDA) Animal Plant Health Inspection Service (APHIS) confirmed the…
On Nov. 4, 2022, Pfizer and BioNTech announced updated data from a Phase 2/3 clinical trial demonstrating a…
On Nov. 3, 2022, the University of Missouri announced a $1.5 million gift from the Orthopedic Foundation for…
On Nov. 2, 2022, Hologic announced that it had been awarded a $19 million contract from the Biomedical…
On Nov. 2, 2022, AIM ImmunoTech announced that the U.S. Food and Drug Administration had granted Orphan Drug…
On Nov. 1, 2022, the U.S. Department of Agriculture announced it was making $30 million in American Rescue…
On Nov. 1, 2022, the National Institutes of Health (NIH) announced that adults with hypertension saw a small,…
On Nov. 1, 2022, Pfizer announced positive top-line data from the Phase 3 clinical trial (NCT04424316) MATISSE (MATernal…
On Nov. 1, 2022, study results published in JAMA found that estimates in this cross-sectional study of 694,660…
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
On Oct. 31, 2022, the National Institutes of Health announced that a clinical trial had found that one…
On Oct. 31, 2022, Moderna announced that it had received approval from the Ministry of Health, Labour and…
On Sept. 3, 2014, the Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences,…
On Oct. 27, 2022, Inovio Pharma announced that it has discontinued its internally funded efforts to develop INO-4800…
On Oct. 27, 2022, the U.S. Department of Agriculture’s Animal Plant Health Inspection Service (APHIS) confirmed the presence…
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…